Dacarba (200 mg) - Dacarbazine- Injection is manufactured by Chandra Bhagat Pharma Pvt. Ltd. and the main constituent generic drug is Dacarbazine- 200 mg.
Bone marrow suppression, hepatic impairment, flu like syndrome, facial flushing, rash, CNS disturbances, blurred vision, paresthesia, anorexia, nausea, vomiting, alopecia, Budd-chiari syndrome.
Metastatic malignant melanoma, hodgkins disease.
Soft tissue sarcomas.
Marrow suppression, hypersensitivity.
Contraindicated during pregnancy and lactation.